Ling Tong
39Patents
8h-index
143Co-inventors
78Inventor score
Filing activity: Feb 6, 2002 → Jun 30, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8178553B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 45 | Active |
| US8569336B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 43 | Active |
| US7504424B2 | Compounds for the treatment of inflammatory disorders | Emerging Cross-Sectional Technologies | 18 | Expired |
| US7488745B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 17 | Active |
| US7524842B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 12 | Active |
| US7067539B2 | Cannabinoid receptor ligands | Chemistry; Metallurgy | 12 | Expired |
| US7482370B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 12 | Expired |
| US7217732B2 | Cannabinoid receptor agonists | Chemistry; Metallurgy | 10 | Expired |
| US7071213B2 | Cannabinoid receptor ligands | Chemistry; Metallurgy | 8 | Expired |
| US7507767B2 | Cannabinoid receptor ligands | Chemistry; Metallurgy | 8 | Expired |
| US7687527B2 | Compounds for the treatment of inflammatory disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US7879890B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 5 | Active |
| US7772263B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 5 | Active |
| US7718702B2 | Cannabinoid receptor ligands | Chemistry; Metallurgy | 5 | Expired |
| US7683085B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 5 | Active |
| USD824343S1 | LED chip | General | 3 | Active |
| US10933056B2 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 2 | Active |
| US8541572B2 | Compounds for the treatment of inflammatory disorders | Human Necessities | 2 | Active |
| US9555038B2 | Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases | Emerging Cross-Sectional Technologies | 2 | Active |
| US11161854B2 | Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US7683088B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 1 | Active |
| US10836775B2 | 6,6-fused heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 1 | Active |
| US9433621B2 | Substituted pyridine and pyrimidine derivatives and their use in treating viral infections | Chemistry; Metallurgy | 1 | Active |
| US7253189B2 | Cannabinoid receptor ligands | Chemistry; Metallurgy | 1 | Expired |
| US11427616B2 | PCSK9 antagonist compounds | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.